PPARG and colonic neoplasm: Loss of PPARγ is implicated in colorectal carcinogenesis, while ligands for PPARγ can suppress breast carcinogenesis in experimental animal models and inhibit anchorage-dependent cell growth in colon cancer cell lines (87).